Zoetis: vaccines, medicines and diagnostics for animals
Zoetis profile: the US animal health company supplying medicines, vaccines and diagnostics for livestock and pets, with USD 9.5 billion revenue in 2025.
Zoetis is a US animal health company developing medicines, vaccines and diagnostics for livestock and companion animals.
United States · Listed on the NYSE (ZTS)
Zoetis is an international animal health company based in the United States and listed on the New York Stock Exchange. It specialises in the health of livestock and companion animals, developing and supplying medicines, vaccines, diagnostics, biopharmaceuticals and digital solutions. It reports its business in a United States segment and an International segment. Its product brands include Draxxin KP, Apoquel and Simparica Trio.
On farms, Zoetis products fit into herd health management: prevention through vaccination, identification of health problems through diagnostics, and veterinary treatment when animals fall ill. Vaccines build immunity before disease appears, while diagnostics show what is affecting a herd so treatment can be targeted. Choices are usually made with the farm's veterinarian as part of the herd health plan, and the range available differs from country to country.
Size of the business
Zoetis had revenue of approximately USD 9.5 billion in 2025, covering both livestock and companion animal products.
What does the company offer?
Zoetis offers veterinary medicines, vaccines and diagnostics, together with solutions that support animal health management on farms and for pets.
How should a buyer make contact?
Zoetis organises its business by country and business unit, and its website lists the local contacts for each market. Farmers usually work through their veterinarian. Enquiries are handled most smoothly when they state the intended application, the scale of the project and the timing required.
The world’s largest agricultural companies
